{"AllianceGenome": "33276", "HGNC": "33276", "MIM": "616284", "_id": "388698", "_version": 1, "accession": {"genomic": ["AL356504.5", "CP068277.2", "DQ118293.1", "HF583542.1", "NC_000001.11", "NC_060925.1"], "protein": ["AAX12417.1", "AAZ99029.1", "CCQ43039.1", "NP_001014364.1", "Q5D862.1"], "rna": ["AY827490.1", "BC029685.1", "BC063543.1", "BC108269.1", "BX095286.1", "NM_001014342.3"], "translation": [{"protein": "NP_001014364.1", "rna": "NM_001014342.3"}, {"protein": "AAX12417.1", "rna": "AY827490.1"}]}, "alias": ["IFPS", "PSS6"], "ensembl": {"gene": "ENSG00000143520", "protein": "ENSP00000373370", "transcript": "ENST00000388718", "translation": [{"protein": "ENSP00000373370", "rna": "ENST00000388718"}], "type_of_gene": "protein_coding"}, "entrezgene": "388698", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 51.65672277, "exp_mis": 622.6032855, "exp_syn": 264.43068, "lof_z": -0.874258709671983, "mis_z": -3.43820800831793, "mu_lof": 4.4852241679e-06, "mu_mis": 5.48767563127e-05, "mu_syn": 2.32645799164e-05, "n_lof": 58.0, "n_mis": 798.0, "n_syn": 320.0, "p_li": 4.64992449263283e-41, "p_null": 0.999999894618294, "p_rec": 1.05381705529679e-07, "syn_z": -2.11850010710621}, "bp": 7176, "cds_end": 152331360, "cds_start": 152323085, "n_exons": 2, "nonpsych": {"exp_lof": 46.713049, "exp_mis": 563.4747999, "exp_syn": 239.2940559, "lof_z": -0.32861684123739, "mis_z": -3.26215130377656, "mu_lof": 4.4852241679e-06, "mu_mis": 5.48767563127e-05, "mu_syn": 2.32645799164e-05, "n_lof": 49.0, "n_mis": 717.0, "n_syn": 294.0, "p_li": 1.67638479801225e-33, "p_null": 0.99999244861712, "p_rec": 7.55138287994181e-06, "syn_z": -2.22654633823052}, "nontcga": {"exp_lof": 47.52016557, "exp_mis": 572.7910433, "exp_syn": 243.27225886, "lof_z": -1.07037073836902, "mis_z": -3.43910377621883, "mu_lof": 4.4852241679e-06, "mu_mis": 5.48767563127e-05, "mu_syn": 2.32645799164e-05, "n_lof": 55.0, "n_mis": 738.0, "n_syn": 283.0, "p_li": 1.68525715378263e-39, "p_null": 0.99999987765194, "p_rec": 1.22348060453829e-07, "syn_z": -1.61275866951153}, "transcript": "ENST00000388718.5"}, "exons": [{"cdsend": 152358884, "cdsstart": 152350609, "chr": "1", "position": [[152348734, 152357647], [152358746, 152358906], [152359955, 152360006]], "strand": -1, "transcript": "NM_001014342", "txend": 152360006, "txstart": 152348734}], "exons_hg19": [{"cdsend": 152331360, "cdsstart": 152323085, "chr": "1", "position": [[152321210, 152330123], [152331222, 152331382], [152332431, 152332482]], "strand": -1, "transcript": "NM_001014342", "txend": 152332482, "txstart": 152321210}], "generif": [{"pubmed": 19384417, "text": "FLG2 and filaggrin may have overlapping and perhaps synergistic roles in the formation of the epidermal barrier, protecting the skin from environmental insults and the escape of moisture by offering precursors of natural moisturizing factors"}, {"pubmed": 19601998, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21531719, "text": "calpain 1 is essential for the proteolytic processing of FLG2 and that deimination accelerates this process."}, {"pubmed": 24184149, "text": "In an African American cohort with Atopic dermatitis (AD), FLG2 mutations were associated with more persistent AD."}, {"pubmed": 24813994, "text": "These findings suggest that filaggrin-2 may play an overlapping role with filaggrin in epithelial cornification; however, it may also have a partially distinct role in the molecular processes of cornification."}, {"pubmed": 26371476, "text": "Data suggest that innate immunity of skin involves FLG2, which is expressed in high abundance in upper epidermis/eccrine sweat glands; C-terminal peptide fragments of FLG2 exhibit antimicrobial functions against replication of Pseudomonas aeruginosa and E. coli."}, {"pubmed": 26858109, "text": "results indicate that filaggrin-2 was expressed in the oral mucosa under certain pathological conditions ( lichen planus, leukokeratosis and leukoplakia), demonstrating that an aberrant protein expression, together with filaggrin, indicates the altered differentiation program including hyperkeratosis that occurs in these diseases."}, {"pubmed": 27304082, "text": "Levels of FLG, FLG2 and SPRR3 mRNAs and proteins were reduced in AD skin."}, {"pubmed": 28928464, "text": "results demonstrate that GATA3 is involved in the regulation of filaggrin and filaggrin-2 expression during inflammatory conditions in the skin."}, {"pubmed": 29758285, "text": "Whole exome sequencing revealed a homozygous nonsense mutation in FLG2, encoding filaggrin 2, which cosegregated with the peeling skin syndrome type A phenotype in the family. The mutation was found to result in decreased FLG2 RNA levels as well as almost total absence of filaggrin 2 in the patient epidermis."}, {"pubmed": 30419833, "text": "sFGL2 levels are induced by HBV infection and correlated with the progression and clinical outcome of HBV-related liver diseases. Thus, sFGL2 may serve as a potential indicator for HBV-related liver diseases."}, {"pubmed": 30528829, "text": "Study data demonstrate that FLG2 N-terminal part, including A-type repeats, is incorporated in cornified envelopes. Thus, FLG2 and FLG have overlapping roles in the homeostasis of the epidermal barrier."}, {"pubmed": 31079484, "text": "In a stop codon variant (rs12568784 G/T) in the FLG2 gene."}, {"pubmed": 32437351, "text": "Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation."}, {"pubmed": 34543471, "text": "Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity."}, {"pubmed": 34984527, "text": "Uncommon variants in FLG2 and TCHHL1 are associated with remission of atopic dermatitis in a large longitudinal US cohort."}, {"pubmed": 36930145, "text": "Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization."}], "genomic_pos": {"chr": "1", "end": 152360006, "ensemblgene": "ENSG00000143520", "start": 152348735, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 152332482, "start": 152321211, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0007155", "pubmed": 29758285, "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048730", "pubmed": [29505760, 29758285], "qualifier": "involved_in", "term": "epidermis morphogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0061436", "qualifier": "involved_in", "term": "establishment of skin barrier"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0061436", "pubmed": 23403047, "qualifier": "involved_in", "term": "establishment of skin barrier"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0001533", "qualifier": "is_active_in", "term": "cornified envelope"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 21630459, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 19384417, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0036457", "qualifier": "is_active_in", "term": "keratohyalin granule"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:1904724", "qualifier": "located_in", "term": "tertiary granule lumen"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0005198", "qualifier": "enables", "term": "structural molecule activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005509", "qualifier": "enables", "term": "calcium ion binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046914", "qualifier": "enables", "term": "transition metal ion binding"}]}, "homologene": {"genes": [[9544, 717480], [9606, 388698]], "id": 134166}, "interpro": [{"desc": "S100/Calcium binding protein 7/8-like, conserved site", "id": "IPR001751", "short_desc": "S100/CaBP7/8-like_CS"}, {"desc": "EF-hand domain", "id": "IPR002048", "short_desc": "EF_hand_dom"}, {"desc": "Filaggrin", "id": "IPR003303", "short_desc": "Filaggrin"}, {"desc": "EF-hand domain pair", "id": "IPR011992", "short_desc": "EF-hand-dom_pair"}, {"desc": "S100/CaBP-9k-type, calcium binding, subdomain", "id": "IPR013787", "short_desc": "S100_Ca-bd_sub"}, {"desc": "EF-Hand 1, calcium-binding site", "id": "IPR018247", "short_desc": "EF_Hand_1_Ca_BS"}, {"desc": "S-100", "id": "IPR034325", "short_desc": "S-100_dom"}], "ipi": "IPI00397801", "map_location": "1q21.3", "name": "filaggrin 2", "other_names": ["filaggrin family member 2", "filaggrin-2", "ifapsoriasin", "intermediate filament-associated and psoriasis susceptibility protein"], "pantherdb": {"HGNC": "33276", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3645678", "ortholog_type": "LDO", "panther_family": "PTHR22571", "taxid": 10090, "uniprot_kb": "Q2VIS4"}], "uniprot_kb": "Q5D862"}, "pathway": {"reactome": [{"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-6798695", "name": "Neutrophil degranulation"}]}, "pfam": "PF01023", "pharmgkb": "PA162388694", "pharos": {"target_id": 6860, "tdl": "Tbio"}, "prosite": "PS50222", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF212512", "relationship": "is"}, {"id": "GNF215104", "relationship": "is"}, {"id": "GNF229214", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1"], "protein": "NP_001014364.1", "rna": "NM_001014342.3", "translation": {"protein": "NP_001014364.1", "rna": "NM_001014342.3"}}, "reporter": {"GNF1H": ["gnf1h03734_at", "gnf1h13198_s_at"], "HG-U133_Plus_2": "1569410_at", "HTA-2_0": "TC01003246.hg.1", "HuEx-1_0": ["2435653", "2435661"], "HuGene-1_1": "7920175", "HuGene-2_1": "16693318"}, "retired": 648187, "summary": "The filaggrin-like protein encoded by this gene is upregulated by calcium, proteolyzed by calpain 1, and is involved in epithelial homeostasis. The encoded protein is required for proper cornification in skin, with defects in this gene being associated with skin diseases. This protein also has a function in skin barrier protection. In fact, in addition to providing a physical barrier, C-terminal fragments of this protein display antimicrobial activity against P. aeruginosa and E. coli. [provided by RefSeq, Jul 2020].", "symbol": "FLG2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C2239455"}, "unigene": "Hs.156124", "uniprot": {"Swiss-Prot": "Q5D862"}}